These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11456392)

  • 1. Primary humoral immune responses to formalin inactivated hemorrhagic fever with renal syndrome vaccine (Hantavax): consideration of active immunization in South Korea.
    Sohn YM; Rho HO; Park MS; Kim JS; Summers PL
    Yonsei Med J; 2001 Jun; 42(3):278-84. PubMed ID: 11456392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.
    Li Z; Zeng H; Wang Y; Zhang Y; Cheng L; Zhang F; Lei Y; Jin B; Ma Y; Chen L
    Hum Vaccin Immunother; 2017 Apr; 13(4):802-807. PubMed ID: 27824286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study on antibody levels of vaccination group and control group after 4 years of immunized with type B inactivated vaccine against hemorrhagic fever with renal syndrome].
    Ruan Y; Liu W; Xu X; Weng SQ; Shao SK; Zhou WQ; Teng Z; Gu HX; Zhu ZY; Xu ZY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):274-6. PubMed ID: 11986705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax™) in healthy adults.
    Song JY; Woo HJ; Cheong HJ; Noh JY; Baek LJ; Kim WJ
    Vaccine; 2016 Mar; 34(10):1289-95. PubMed ID: 26826547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long term epidemiological effects of vaccination on hemorrhagical fever with renal syndrome (HFRS) in Shaanxi provincial HFRS epidemic areas].
    Wang JJ; Wei ZZ; Wei J; Ma CA; Dong JH; Lu XL; Zheng Y; Yu PB; Qu JH; Dong LF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):309-12. PubMed ID: 22613385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on inactivated epidemic hemorrhagic fever tissue culture vaccine in humans.
    Zhu ZY; Tang HY; Li YJ; Weng JQ; Yu YX; Zeng RF
    Chin Med J (Engl); 1994 Mar; 107(3):167-70. PubMed ID: 7916278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serological surveillance on vaccine against hemorrhagic fever with renal syndrome].
    Gong ZY; Weng JQ; Zhao ZY; Chen YT; Zhu AG; Fu GM; Fang CF; Zhu ZY; Chen EF; Wang CZ; Wang W; Lei LH; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):400-2. PubMed ID: 15231163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of a modified three-dose priming and booster schedule for the Hantaan virus vaccine (Hantavax): A multi-center phase III clinical trial in healthy adults.
    Song JY; Jeong HW; Yun JW; Lee J; Woo HJ; Bae JY; Park MS; Choi WS; Park DW; Noh JY; Cheong HJ; Kim WJ
    Vaccine; 2020 Nov; 38(50):8016-8023. PubMed ID: 33131933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systems Vaccinology Approach Reveals the Mechanisms of Immunogenic Responses to Hantavax Vaccination in Humans.
    Khan A; Shin OS; Na J; Kim JK; Seong RK; Park MS; Noh JY; Song JY; Cheong HJ; Park YH; Kim WJ
    Sci Rep; 2019 Mar; 9(1):4760. PubMed ID: 30886186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on immunogenicity and safety of bivalent inactivated vaccine against hemorrhagic fever with renal syndrome].
    Ruan Y; Xu X; Liu W; Deng X; Weng S; Zhou W; Wang Q; Chen L; Fang L; Xu Z; Yan Q; Liu W; Dong G; Gu H; Yu Y; Xu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Nov; 33(6):340-2. PubMed ID: 11864504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety and immunogenicity of inactivated bivalent EHF vaccine in humans].
    Liu W; Xu X; Ruan Y; Weng S; Liu W; Zhou W; Dong G; Gu H; Zhu Z; Xu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):445-7. PubMed ID: 11860832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells.
    Choi Y; Ahn CJ; Seong KM; Jung MY; Ahn BY
    Vaccine; 2003 May; 21(17-18):1867-73. PubMed ID: 12706671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of subclinical infection rates between vaccinated group with type I inactivated vaccine against hemorrhagic fever and controls].
    Ruan Y; Xu X; Shao S; Tong Z; Weng S; Zhou W; Gu H; Zhu Z; Xu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Sep; 33(5):308-10. PubMed ID: 11864500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventive effects of three kinds of inactive vaccines against epidemic hemorrhagic fever (EHF) after 5 years of vaccination].
    Chen H; Tang L; Luo Z; Zhang J; Zhang Z; Hu M; Weng J; Liu W; Zhao T; Liu W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Oct; 21(5):347-8. PubMed ID: 11860813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.
    Li C; Liu F; Liang M; Zhang Q; Wang X; Wang T; Li J; Li D
    Vaccine; 2010 Jun; 28(26):4294-300. PubMed ID: 20433802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Passage adaptability of candidate strains for hemorrhagic fever with renal syndrome purified vaccine in Vero cells and their immunogenicity].
    Chen W; Xue CF; Liu JQ; Li ZY; Fan YX; Xu L; Liao H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):129-32. PubMed ID: 12869992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
    Hooper JW; Moon JE; Paolino KM; Newcomer R; McLain DE; Josleyn M; Hannaman D; Schmaljohn C
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():110-7. PubMed ID: 24447183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of an inactivated vaccine against hantaviruses.
    Cho HW; Howard CR; Lee HW
    Intervirology; 2002; 45(4-6):328-33. PubMed ID: 12602351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines for HFRS: laboratory and clinical studies.
    Schmaljohn CS; Spik KW; Hooper JW
    Virus Res; 2014 Jul; 187():91-6. PubMed ID: 24370868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of HFRS vaccination against hemorrhagic fever with renal syndrome during 1999-2000 in Laiwu City].
    Wei K; Xie Y; Yao Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):283-5. PubMed ID: 12665942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.